Galapagos NV
GLPG
#4540
Rank
NZ$3.71 B
Marketcap
NZ$55.59
Share price
2.21%
Change (1 day)
18.54%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): NZ-$0.80

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.58. In 2024 the company made an earnings per share (EPS) of NZ$2.00 a decrease over its 2023 EPS that were of NZ$6.10.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.80-139.71%
2024NZ$2.00-67.16%
2023NZ$6.10-199.64%
2022NZ-$6.1299.03%
2021NZ-$3.08-68.98%
2020NZ-$9.92-298.06%
2019NZ$5.01-554.64%
2018NZ-$1.10-77.18%
2017NZ-$4.83-326.21%
2016NZ$2.13-134.19%
2015NZ-$6.24-371.34%
2014NZ$2.30-445.98%
2013NZ-$0.6632.88%
2012NZ-$0.50-82.07%
2011NZ-$2.79-817.9%
2010NZ$0.3912.73%
2009NZ$0.34-120.79%
2008NZ-$1.66-37.67%
2007NZ-$2.6639.64%
2006NZ-$1.9128.17%
2005NZ-$1.496.25%
2004NZ-$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
NZ$5.22-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$17.95-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.37-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$2.32-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ-$2.53 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.85-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.08-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$6.18-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$13.06-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA